Medicare Enrolled
Dr. Mahmoud Aly, M.D.
Hematology & Oncology · Staten Island, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aly from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aly?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aly
Dr. Mahmoud Aly is a hematology & oncology specialist in Staten Island, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Aly performed 34,775 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Aly received a total of $3,695 from 33 pharmaceutical and/or device companies across 219 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aly is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 15% volume in NY
$3,695 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗34,775
Medicare services
Top 15% in NY for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
24,800 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,360 | $6 | $18 |
| Denosumab injection (Prolia/Xgeva) | 2,340 | $18 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
974 | $101 | $342 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
707 | $0 | $0 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
347 | $0 | $15 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
328 | $8 | $15 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
325 | $8 | $25 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
273 | $62 | $145 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
219 | $13 | $65 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
206 | $28 | $95 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
150 | $1 | $15 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
142 | $48 | $96 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
138 | $68 | $281 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
115 | $129 | $275 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
87 | $1 | $2 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $142 | $354 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
53 | $15 | $65 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
52 | $23 | $85 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
43 | $1 | $15 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $111 | $175 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $133 | $472 |
| New patient office visit, complex (60-74 min) | 12 | $196 | $493 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
3.1% high complexity
90.9% medium
6.0% routine
Industry Payment Transparency
Open Payments through 2022 ↗$3,695
Total received (2018-2022)
Avg $739/year across 5 years
Top 39% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
219
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2022
$135
2021
$14
2020
$337
2019
$1,480
2018
$1,729
Payments by company (2022)
PFIZER INC.
$70
Novartis Pharmaceuticals Corporation
$38
BeiGene USA, Inc.
$27
Top 3 companies account for 100.0% of 2022 payments
All-time payments by company (2018-2022) ›
Janssen Biotech, Inc.
$411
PFIZER INC.
$404
Novartis Pharmaceuticals Corporation
$285
AstraZeneca Pharmaceuticals LP
$223
Genentech USA, Inc.
$218
Merck Sharp & Dohme Corporation
$208
E.R. Squibb & Sons, L.L.C.
$200
Astellas Pharma US Inc
$182
Seagen Inc.
$142
Incyte Corporation
$129
Amgen Inc.
$121
GENZYME CORPORATION
$121
SANOFI-AVENTIS U.S. LLC
$115
Alexion Pharmaceuticals, Inc.
$101
Gilead Sciences, Inc.
$83
Bayer HealthCare Pharmaceuticals Inc.
$79
Exelixis Inc.
$68
Takeda Pharmaceuticals U.S.A., Inc.
$60
Clovis Oncology, Inc.
$59
AbbVie, Inc.
$56
Janssen Pharmaceuticals, Inc
$56
Lilly USA, LLC
$48
Taiho Oncology, Inc.
$48
Eisai Inc.
$47
Seattle Genetics, Inc.
$42
Rigel Pharmaceuticals, Inc.
$36
AMAG Pharmaceuticals, Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
BeiGene USA, Inc.
$27
Advanced Accelerator Applications
$21
EISAI INC.
$20
Pharmacyclics LLC, An AbbVie Company
$15
Celgene Corporation
$12
Top 3 companies account for 29.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · Avastin · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · DARZALEX · ELIQUIS · ELITEK · EMEND · Erleada · FASLODEX · FERAHEME · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · Kyprolis · LENVIMA · LUTATHERA · Lenvima · Lonsurf · MEKINIST · MYLOTARG · NINLARO · OPDIVO · PADCEV · PREVNAR 13 · PREVNAR 20 · PROMACTA · RYDAPT · Rubraca · SOLIRIS · SPRYCEL · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · Tavalisse · VENCLEXTA · VERZENIO · Venclexta · XARELTO · XOSPATA · XTANDI · Xofigo · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
651
County median income
$98,290
Nearest hospital to ZIP centroid (approximate)
STATEN ISLAND UNIVERSITY HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2022 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aly is a mixed practice specialist, with above-average Medicare volume (top 15% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aly experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Aly performed 24,800 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Aly receive payments from pharmaceutical companies?
Yes. Dr. Aly received a total of $3,695 from 33 companies across 219 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aly's costs compare to other hematology & oncology specialists in Staten Island?
Dr. Aly's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aly) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Staten Island
Browse hematology & oncology specialists in Staten Island ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology